MPTP
Overview
MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a chemical compound that is of significant interest in the field of neuroscience and pharmacology. It is a neurotoxin that selectively destroys dopaminergic neurons in the substantia nigra, leading to symptoms similar to those of Parkinson's disease.
History
MPTP was first synthesized in the 1970s as a byproduct during the illicit production of the synthetic opioid MPPP. It gained notoriety in the early 1980s when it was discovered that individuals who had consumed MPTP-contaminated drugs developed severe and irreversible parkinsonism. This led to its use as a tool for creating animal models of Parkinson's disease for research purposes.
Mechanism of Action
MPTP itself is not directly toxic. It crosses the blood-brain barrier and is metabolized by the enzyme monoamine oxidase B (MAO-B) in glial cells to form MPP+ (1-methyl-4-phenylpyridinium), which is the active toxic agent. MPP+ is taken up by dopaminergic neurons via the dopamine transporter and accumulates in the mitochondria, where it inhibits complex I of the electron transport chain. This inhibition leads to mitochondrial dysfunction, oxidative stress, and ultimately, neuronal death.
Clinical Significance
The discovery of MPTP's effects on the brain has provided valuable insights into the pathophysiology of Parkinson's disease. It has been used extensively in research to develop and test new therapeutic strategies for the treatment of Parkinson's disease. MPTP-induced parkinsonism in animal models has helped in understanding the role of dopamine in motor control and the potential for neuroprotective agents to prevent or slow the progression of neurodegenerative diseases.
Safety and Handling
Due to its potent neurotoxic effects, MPTP is handled with extreme caution in research settings. It is classified as a hazardous substance, and appropriate safety protocols must be followed to prevent accidental exposure.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD